Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Gibraltar Laboratories, Inc.
EIR
•Gibraltar Laboratories, Inc.•February 22, 2017

Gibraltar Laboratories, Inc. – FDA EIR, Feb 22, 2017

Record Details

An FDA inspection of Gibraltar Laboratories, Inc., located in Fairfield, NJ, was conducted from February 13 to February 22, 2017. This inspection, initiated under the New Jersey District’s FY’17 Drug Inspections Work-plan, focused on the Quality, Laboratory Control, and Facility and Equipment Systems. The regulatory framework for the inspection included CPGM 7356.002 for Drug Manufacturing Inspections and CPGM 7371.001 for Animal Drug Manufacturing Inspections. The facility, which provides microbiology and analytical chemistry testing, and has recently incorporated terminal sterilization, did not receive any formal FDA-483 Inspectional Observations. However, the inspection concluded with significant discussions with management regarding several areas needing improvement. Main issues identified included inadequate thorough review of testing documentation, which resulted in instances of microbiology technicians using incorrect test methods or failing to follow proper protocols. Additionally, a dry heat sterilizer (GBL #433344) in the sterilization room was pending Performance Qualification (PQ) before use, and a pH Meter lacked a data printer to supplement manual data recordings. In response, management committed to revising standard operating procedures (SOPs) to enhance quality checks for test method assignment and sample verification, integrating a data printer with the pH Meter, and completing the Performance Qualification for the dry heat sterilizer.

Company
Gibraltar Laboratories, Inc.
Inspection date
February 22, 2017
Product type
drugs
Office
New Jersey District Office
People
  • Daniel Prince (company_representative)
  • Zakaria I. Ganiyu ( Investigator )
  • Mahesh Patel (company_representative)
  • Jozef Mastej (company_representative)
View Company Profile

ID · 0d9a6635-9586-488c-8bf0-93b5d5a6fb20

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Gibraltar Laboratories, Inc.
  • EIR - 2019-11-20November 20, 2019
  • EIR - 2015-02-03February 3, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gibraltar Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.